In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Mark Stevenson, Vice President and Chief Operations Officer at Thermo Fisher Scientific. Mark talks to Mike about day-to-day pandemic effects on operations and priorities, and how they have redistributed resources to help combat impact and maintain longer-term business focus. He also explores how he feels the pandemic will change supply chains moving forward, as well as the life science ecosystem in general. Mark goes on to discuss exciting new developments for his company, including their bid to acquire Qjagen, drug discovery tools and innovation across the life sciences industry. Mark explains how important it is to work with other innovators in the industry and the growing clusters of innovators to look out for across the globe. Hosted on Acast. See acast.com/privacy for more information.